Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

EDQM updates policy on suspension and withdrawal of CEPs

This article was originally published in SRA

Executive Summary

The European Directorate for the Quality of Medicines & HealthCare (EDQM) has revised its policy on suspending and withdrawing the certificates of suitability (CEPs) it grants to manufacturers to show that a substance used to prepare a drug complies with the European Pharmacopoeia monograph1,2.

Advertisement
Advertisement
UsernamePublicRestriction

Register

PS116201

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel